Endogenous murine tau promotes neurofibrillary tangles in 3xTg-AD mice without affecting cognition

David Baglietto-Vargas1, Masashi Kitazawa2, Elaine J Le1

  • 1Department of Neurobiology and Behavior, Institute for Memory Impairments and Neurological Disorders, University of California, Irvine, CA 92697-4545, USA.

Neurobiology of Disease
|November 2, 2013
PubMed

Insights

Deleting mouse tau (mtauKO) in a mouse model of Alzheimer's disease (AD) reduced tau accumulation but did not worsen cognitive deficits. This suggests endogenous tau plays a complex role in AD pathology.

Area of Science:

  • Neuroscience
  • Pathology
  • Genetics

Background:

  • Endogenous murine tau may influence human tauopathy progression.
  • Understanding tau's role is crucial for Alzheimer's disease (AD) research.

Purpose of the Study:

  • To investigate the pathological consequences of endogenous tau in a combined plaque and tangle mouse model.
  • To develop a novel transgenic mouse model (3xTg-AD/mtauKO) for studying tauopathy.

Main Methods:

  • Crossed 3xTg-AD mice with mtauKO mice to create 3xTg-AD/mtauKO mice.
  • Analyzed tau loads (soluble and insoluble fractions) and hyperphosphorylation levels.
  • Assessed cognitive function using a spatial memory task.

Main Results:

  • 3xTg-AD/mtauKO mice exhibited lower tau loads and reduced soluble tau hyperphosphorylation compared to 3xTg-AD mice.
  • Endogenous mouse tau in 3xTg-AD mice was hyperphosphorylated and co-aggregated with human tau.
  • Cognitive performance in 3xTg-AD/mtauKO mice was similar to 3xTg-AD mice, with no additional impairment.

Conclusions:

  • Endogenous tau deletion reduces tau pathology burden in this AD model.
  • Despite reduced tau pathology, cognitive deficits were not exacerbated, indicating a complex role for endogenous tau.
  • Findings enhance understanding of tau's role in AD and inform the development of new AD models.

Related Concept Videos